Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 10

1.
2.

Geldanamycin: the prototype of a class of antitumor drugs targeting the heat shock protein 90 family of molecular chaperones.

Ochel HJ, Eichhorn K, Gademann G.

Cell Stress Chaperones. 2001 Apr;6(2):105-12. Review. No abstract available. Erratum in: Cell Stress Chaperones 2001 Jul;6(3):295.

3.

Geldanamycin as a potential anti-cancer agent: its molecular target and biochemical activity.

Neckers L, Schulte TW, Mimnaugh E.

Invest New Drugs. 1999;17(4):361-73. Review.

PMID:
10759403
4.

[Molecular chaperone HSP90 as a novel target for cancer chemotherapy].

Miyata Y.

Nihon Yakurigaku Zasshi. 2003 Jan;121(1):33-42. Review. Japanese.

PMID:
12617036
5.

Altered states: selectively drugging the Hsp90 cancer chaperone.

Workman P.

Trends Mol Med. 2004 Feb;10(2):47-51. Review.

PMID:
15106614
6.

The Hsp90 chaperone complex as a novel target for cancer therapy.

Goetz MP, Toft DO, Ames MM, Erlichman C.

Ann Oncol. 2003 Aug;14(8):1169-76. Review.

7.
8.

Geldanamycin analogs.

Sausville EA.

J Chemother. 2004 Nov;16 Suppl 4:68-9. Review.

PMID:
15688614
9.

Chaperone-mediated destruction of erbB2: relevance to tyrosine kinase inhibitors.

Gee JM.

Breast Cancer Res. 2002;4(5):205-6. Review. No abstract available.

10.

Extracellular Hsp90 (eHsp90) as the actual target in clinical trials: intentionally or unintentionally.

Li W, Tsen F, Sahu D, Bhatia A, Chen M, Multhoff G, Woodley DT.

Int Rev Cell Mol Biol. 2013;303:203-35. doi: 10.1016/B978-0-12-407697-6.00005-2. Review.

Items per page

Supplemental Content

Write to the Help Desk